Claudia Tosti

ORCID: 0000-0001-5814-7265 · 37 papers in corpus
other 2019
Human Reproduction ·doi:10.1093/humrep/dez182

STUDY QUESTION: Are selective markers for the neuronal differentiation such as microtubule-associated protein 2 (MAP-2) and synaptophysin (SYP) as well as the nerve growth factor (NGF) expressed by fibroids, myometrium and eutopic endometri…

review 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.01.013

Adenomyosis is a benign uterine condition affecting women at various ages with different symptoms. The management of these patients is still controversial. Few clinical studies focusing on medical or surgical treatment for adenomyosis have …

2017
·doi:10.5301/je.5000270

Background The aim of the study was to evaluate the clinical efficacy of long-term vaginal danazol treatment in fertile age women with adenomyosis on pain symptoms and abnormal uterine bleeding (AUB). Methods A retrospective study on 66 you…

review 2017
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2017.06.016

Adenomyosis is a uterine disorder becoming more commonly diagnosed in women of reproductive age because of diagnostic imaging advancements. The new epidemiological scenario and the clinical evidence of pelvic pain, abnormal uterine bleeding…

observational 2017
Human Reproduction ·doi:10.1093/humrep/dex088

STUDY QUESTION: What is the relationship between endometriosis phenotypes superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), deep infiltrating endometriosis (DIE) and the adenomyosis appearance by magnetic resonance ima…

review 2016
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2015.12.017

A panel of experts in the field of endometriosis expressed their opinions on management options in a 28-year-old patient, attempting pregnancy for 1 year, with severe cyclic pelvic pain and with clinical examination and imaging techniques s…

review 2016
·doi:10.5301/je.5000261

Adenomyosis is a benign gynecological disorder associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia and infertility, requiring a life-long management plan through medical or surgical treatment. The choice depends on woman's …

other 2016
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719116657192

OBJECTIVE: Adenomyosis is a uterine disorder characterized by dysmenorrhea, dyspareunia, abnormal uterine bleeding, and infertility. Pathogenesis indicates that endometrial cells invade and proliferate within myometrium, and inflammatory me…

review 2016
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2016.05.032

Endometriotic lesions are associated with hormonal imbalance, including increased estrogen synthesis, metabolism and progesterone resistance. These hormonal changes cause increased proliferation, inflammation, pain and infertility. Hormonal…

observational 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.12.127

OBJECTIVE: To investigate the possible correlation between maternal characteristics, in utero and early neonatal life exposures, and the development of endometriosis in adult life. DESIGN: Case-control study. SETTING: University hospital.…

review 2016

Endometriosis is a benign gynecologic disease, affecting women of reproductive age associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. Ovarian endometrioma (OMA), superficial peritoneal endometriosis (SPE), and d…

lab-animal 2016
Expert opinion on therapeutic targets ·doi:10.1080/14728222.2016.1180367

OBJECTIVE: Mitogen-activated protein kinases (MAPKs) are involved in the proliferation and survival of endometriotic lesions. Vemurafenib (PLX4032) is a novel protein kinase inhibitor that targets BRAF, a member of the MAPK pathway. The pre…

other 2016
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2016.07.009

Ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE) are the most severe forms of endometriosis, but different pathogenetic mechanisms and clinical symptoms distinguish these two forms. Corticotrophin-releasing hormone (CRH)…

2015
·doi:10.5301/je.5000232

Background The aim of this study was to assess the efficacy of dienogest treatment in improving quality of life in women with endometriosis. Methods This was a prospective observational multicenter study at the universities of Siena, Milano…

nonrandomized-trial 2015
Gynecologic and obstetric investigation ·doi:10.1159/000368776

BACKGROUND: The aim of the study was to investigate the levels of perceived stress in a group of women with a long-term history of endometriosis in conjunction with surgical and/or medical treatments. METHODS: A clinical trial was conducte…

other 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.10.024

OBJECTIVE: To assess whether healthy endometrium, eutopic endometrium, and endometriotic lesions express nerve growth factor (NGF), microtubule-associated protein 2 (MAP-2), and synaptophysin (SYP). DESIGN: Molecular study in tissue extrac…

case-report 2015
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2015.01.021

A panel of experts in the field of endometriosis expressed their opinions on management options in a 35-year-old patient desiring pregnancy with a history of previous surgery for endometrioma and bowel obstruction symptoms. Many questions t…

2015
·doi:10.1007/s40619-015-0111-8
review 2015
Expert opinion on therapeutic targets ·doi:10.1517/14728222.2015.1090974

INTRODUCTION: The pathogenesis of endometriosis, a common benign disease, remains ill-defined, although it is clear that chronic inflammation plays a crucial role through mitogen-activated protein kinase (MAPK) signaling pathways. All curre…

other 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.05.032

OBJECTIVE: To evaluate the expression pattern of activins and related growth factor messenger RNA (mRNA) levels in adenomyotic nodules and in their endometrium. DESIGN: Prospective study. SETTING: University hospital. PATIENT(S): Symptom…

review 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115592713

Endometriosis is a benign gynecologic disease, affecting women of reproductive age associated with chronic pelvic pain, dysmenorrhea, dyspareunia and infertility. Ovarian endometrioma (OMA), superficial peritoneal endometriosis (SPE), and d…

observational 2015
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology ·doi:10.1002/uog.14834

OBJECTIVES: To investigate whether there are sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis and to examine their association with symptoms of dysmenorrhea and abnormal uterine bleeding.…

review 2014
Women's health (London, England) ·doi:10.2217/whe.14.20

Although the correlation between endometriosis, junctional zone (JZ) hyperplasia and adenomyosis is still debated, the correlation among JZ and different etiological and clinical aspects is, today, well recognized. Starting from that, clini…

other 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719114522520

OBJECTIVES: Deep infiltrating endometriosis (DIE) represents the most complex form of endometriosis and its treatment is still challenging. The coexistence of DIE with other appearances of endometriosis stimulates new studies to improve the…

2014
·doi:10.1002/uog.13564

Deep infiltrating endometriosis (DIE) represents the most complex form of endometriosis and its treatment is still challenging. The coexistence of DIE with other appearances of endometriosis stimulates new studies to improve the preoperativ…